| Matthew Dean Dobbertin, DO | |
|
14092 Boys Town Hospital Road, Boys Town, NE 68010 | |
| (531) 355-1449 | |
| (531) 355-0001 |
| Full Name | Matthew Dean Dobbertin |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 14 Years |
| Location | 14092 Boys Town Hospital Road, Boys Town, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992019442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 6396 (Nebraska) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 982 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Father Flanagans Boys Home | 9638165400 | 72 |
News Archive
Most people remember where they were when the twin towers collapsed in New York ... new research reveals why that may be the case.
MedPlexus today announced the creation of their "Cash for Clunkers" Program. The "stimulus package," which is available September 1, 2009, grants cash payments of $3,000 to $5,000 to doctors who replace their previous EHR and/or practice management platforms with MedPlexus integrated platforms.
The increased focus on helping surgical oncology patients recover from surgery sooner and more completely has implications beyond the operating room.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
A team of researchers from the National University of Singapore (NUS) has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
› Verified 8 days ago
| Entity Name | Father Flanagans Boys Home |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295821825 PECOS PAC ID: 9638165400 Enrollment ID: O20040426000622 |
News Archive
Most people remember where they were when the twin towers collapsed in New York ... new research reveals why that may be the case.
MedPlexus today announced the creation of their "Cash for Clunkers" Program. The "stimulus package," which is available September 1, 2009, grants cash payments of $3,000 to $5,000 to doctors who replace their previous EHR and/or practice management platforms with MedPlexus integrated platforms.
The increased focus on helping surgical oncology patients recover from surgery sooner and more completely has implications beyond the operating room.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
A team of researchers from the National University of Singapore (NUS) has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Dean Dobbertin, DO 555 N 30th St, Omaha, NE 68131-2136 Ph: (402) 498-6540 | Matthew Dean Dobbertin, DO 14092 Boys Town Hospital Road, Boys Town, NE 68010 Ph: (531) 355-1449 |
News Archive
Most people remember where they were when the twin towers collapsed in New York ... new research reveals why that may be the case.
MedPlexus today announced the creation of their "Cash for Clunkers" Program. The "stimulus package," which is available September 1, 2009, grants cash payments of $3,000 to $5,000 to doctors who replace their previous EHR and/or practice management platforms with MedPlexus integrated platforms.
The increased focus on helping surgical oncology patients recover from surgery sooner and more completely has implications beyond the operating room.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
A team of researchers from the National University of Singapore (NUS) has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
› Verified 8 days ago
Dr. Douglas F Spellman, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 14092 Boys Town Hospital Road, Boys Town, NE 68010 Phone: 531-355-1449 Fax: 531-355-0001 | |
Dr. Kathi J Curry, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 14092 Boys Town Hospital Road, Boys Town, NE 68010 Phone: 531-355-1449 Fax: 531-355-1669 | |
Dr. Laura A Novoa, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 14092 Boys Town Hospital Road, Boys Town, NE 68010 Phone: 531-355-1449 Fax: 531-355-0001 | |
Isabella Herman, MD, PHD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 14080 Boys Town Hospital Rd, Boys Town, NE 68010 Phone: 531-355-7420 | |
Dr. Jennifer Inbarasu, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 14092 Boys Town Hospital Rd, Boys Town, NE 68010 Phone: 531-355-1449 |